Moleculin Biotech (MBRX) traded up 10.36 % during a 24 hours period ending at 03:51 AM Central Europe on Tuesday 27th. One Moleculin Biotech stock can currently be bought for about USD 7.08 on popular exchanges. Current supply of Moleculin Biotech stocks is 1 mn. Moleculin Biotech has a current market capitalization of USD 6.6 mn and approximately USD 178.1 k worth of Moleculin Biotech was traded on exchanges in the last 24 hours. Since last month end, Moleculin Biotech has traded 1,046.38 % up. Simple moving average of last 200 days is at USD 2.66. The highest price of past 52 weeks was recorded at USD 16.4 on 09/14/2026. 52 weeks low was at USD 0.16 on 08/03/2026.
Here is how related stocks have performed in the past 24 hours:
Invesque (IVQ-U.TO) traded up 11.11 % and now trades at USD 0.1. Current market capitalisation for Invesque is USD 5.7 mn.
Soligenix (SNGX) traded up 2.78 % and now trades at USD 0.35. Soligenix has a market capitalisation of USD 7.9 mn.
Innovative Eyewear (LUCY) traded up 0.7 % and now trades at USD 0.79. Current market capitalisation for Innovative Eyewear is USD 7.6 mn.
Alaunos Therapeutics (TCRT) traded down -25 % and now trades at USD 2.13. Current market capitalisation for Alaunos Therapeutics is USD 7.8 mn.
Biomerica (BMRA) traded flat 0 % and now trades at USD 1.72. Current market capitalisation for Biomerica is USD 7.7 mn.
About Moleculin Biotech
Moleculin Biotech, Inc. is a preclinical and clinical-stage pharmaceutical company specializing in the development of anti-cancer drug candidates. The company is headquartered in Houston, Texas, and operates within the Health Care sector, with a focus on Biotechnology as its industry. Moleculin Biotech offers drugs for skin diseases treatment and cancer care, with their website accessible under www.moleculin.com and their stocks trading on the Nasdaq stock exchange. The date of their Initial Public Offering (IPO) was June 2nd, 2016.
